These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2527227)

  • 1. Role of thromboxane receptors in Forssman shock in guinea pigs.
    Schumacher WA; Steinbacher TE; Allen GT; Ogletree ML
    J Appl Physiol (1985); 1989 Jul; 67(1):44-51. PubMed ID: 2527227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboxane receptor activation during bronchospasm induced by platelet-activating factor.
    Schumacher WA; Steinbacher TE
    J Lipid Mediat; 1991; 4(1):97-110. PubMed ID: 1832573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of thromboxane receptor activation in the bronchospastic response to endothelin.
    Schumacher WA; Steinbacher TE; Allen GT; Ogletree ML
    Prostaglandins; 1990 Jul; 40(1):71-9. PubMed ID: 2143841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protamine-induced pulmonary hypertension in heparinized monkeys and pigs is inhibited by the thromboxane receptor antagonist SQ 30,741.
    Schumacher WA; Heran CL; Ogletree ML
    Eicosanoids; 1990; 3(2):87-93. PubMed ID: 2144979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interference of levamisole with Forssman shock.
    Casacó A; Carvajal D; Friman M; Noa M
    Thromb Res; 1990 Aug; 59(3):629-37. PubMed ID: 2237831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of three novel thromboxane A2 receptor antagonists (S-1452, AA-2414 and ONO-3708) on the increase in pulmonary pressure caused by Forssman anaphylaxis in guinea-pigs.
    Nagai H; Kumimoto M; Yoshitake K; Iwama T; Arimura A; Koda A
    Prostaglandins Leukot Essent Fatty Acids; 1992 Mar; 45(3):233-8. PubMed ID: 1534171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of Forssman-induced bronchospasm and their inhibition.
    Butler KD; Smith JR
    Br J Pharmacol; 1981 May; 73(1):25-32. PubMed ID: 7284697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of therapeutic effect of high-dose intravenous immunoglobulin. Attenuation of acute, complement-dependent immune damage in a guinea pig model.
    Basta M; Kirshbom P; Frank MM; Fries LF
    J Clin Invest; 1989 Dec; 84(6):1974-81. PubMed ID: 2687331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Increase in pulmonary resistance induced by Forssman antiserum in guinea pigs].
    Nakagami K; Kobayashi T; Takayanagi N; Yano J; Miura M
    Nihon Yakurigaku Zasshi; 1983 Dec; 82(6):429-41. PubMed ID: 6607868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An ultrastructural analysis of the vascular damage in the lethal and sublethal Forssman reaction in the guinea-pig.
    Baker JR; Bullock GR; Butler KD; Williamson IH; White AM
    Br J Exp Pathol; 1985 Dec; 66(6):709-18. PubMed ID: 3878720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of thromboxane (Tx) A2 in guinea pig Forssman shock and the effect of OKY-046, Tx A2 synthetase inhibitor.
    Nagai H; Yakuo I; Inagaki N; Koda A; Hamano S; Ujiie A; Nakazawa M
    Prostaglandins Leukot Med; 1987 Feb; 26(2):133-41. PubMed ID: 3470814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiotoxicity of Forssman antibodies in in vitro perfusion experiments.
    Chen H; Diakun KR; Milgrom F
    Immunol Commun; 1984; 13(6):571-6. PubMed ID: 6335882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnitude of thromboxane receptor antagonism necessary for antithrombotic activity in monkeys.
    Schumacher WA; Heran CL; Goldenberg HJ; Harris DN; Ogletree ML
    Am J Physiol; 1989 Mar; 256(3 Pt 2):H726-34. PubMed ID: 2522282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-allergic effects of (E)-3-[p-(1H-imidazol-1-ylmethyl)phenyl]-2-propenoic acid (OKY-046), a specific thromboxane (TX) A2 synthetase inhibitor: effect of OKY-046 on II-IV type allergic reactions].
    Kikuchi S; Takehana Y; Hamano S; Ichikawa K; Komatsu H; Okegawa T; Ikeda S
    Nihon Yakurigaku Zasshi; 1990 Mar; 95(3):131-7. PubMed ID: 2141317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of thromboxane receptor antagonists on venous thrombosis in rats.
    Schumacher WA; Heran CL
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1109-15. PubMed ID: 2522985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the thromboxane A2 receptor antagonist SQ 30,741 on ultimate myocardial infarct size, reperfusion injury and coronary flow reserve.
    Grover GJ; Schumacher WA
    J Pharmacol Exp Ther; 1989 Feb; 248(2):484-91. PubMed ID: 2521899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of the short-acting thromboxane receptor antagonist, SQ 30,741, in thrombolytic and vasospastic models in monkeys.
    Schumacher WA; Heran CL; Hartl KS; Ogletree ML
    J Pharmacol Exp Ther; 1990 May; 253(2):841-6. PubMed ID: 2140131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 1-[3-(4-benzhydryl-1-piperazinyl)propyl]-3- (1H-imidazol-1-ylmethyl)-1H-indole-6-carboxylic acid with thromboxane A2 synthetase inhibitory and H1-blocking activities on anaphylactic bronchospasm.
    Nakamura S; Shirahase H; Kanda M; Wada K; Kamiya S; Matsui H; Kurahashi K
    Arzneimittelforschung; 1996 Nov; 46(11):1067-71. PubMed ID: 8955866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the thromboxane A2-receptor antagonists, SQ 29,548 and SQ 28,668, on the pulmonary hypertensive response to endotoxemia in swine.
    Schumacher WA; Adams HD; Ogletree ML
    Pharmacology; 1987; 34(6):301-8. PubMed ID: 2958886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cardioprotective effects of the thromboxane receptor antagonist SQ 30,741 are not reversed by aspirin.
    Grover GJ; Parham CS; Schumacher WA
    Basic Res Cardiol; 1991; 86(2):99-106. PubMed ID: 1831610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.